Young Dong Yooa,1, Su Ran Muna,1, Chang Hoon Jia, Ki Woon Sunga, Keum Young Kanga, Ah Jung Heoa, Su Hyun Leea, Jee Young Anb, Joonsung Hwangc, Xiang-Qun Xied,e,f,g,h, Aaron Ciechanovera,i,2, Bo Yeon Kimc,2, and Yong Tae Kwona,j,2
aProtein Metabolism Medical Research Center and Department of Biomedical Sciences, College of Medicine, Seoul National University, Jongno-gu, 03080 Seoul, Korea; bCenter for Genome Engineering, Institute for Basic Science, Yuseong-gu, 34126 Daejeon, Korea; cAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 28116 Cheongju, Korea; dDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15260; eNational Center of Excellence for Computational Drug Abuse Research, University of Pittsburgh, Pittsburgh, PA 15260; fDrug Discovery Institute, University of Pittsburgh, Pittsburgh, PA 15260; gDepartment of Computational Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260; hDepartment of Structural Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260; iTechnion Integrated Cancer Center, Faculty of Medicine, Technion-Israel Institute of Technology, 31096 Haifa, Israel; and jIschemic/Hypoxic Disease Institute, College of Medicine, Seoul National University, Jongno-gu, 03080 Seoul, Korea
1Y.D.Y. and S.R.M. contributed equally to this work.
2To whom correspondence may be addressed.